MedPath

Comparison of helicobacter pylori eradication rate with four different quadruple regimens in dyspeptic patients.

Phase 2
Conditions
Infection with Helicobacter pylori.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT2013010612024N1
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
270
Inclusion Criteria

Patients with positive rapid urea’s test that confirmed with histological finding of helicobacter pylori infection and chronic gastritis were entered in study.
Persons under 18 years of age at the time of endoscopy; those in the last month or bismuth compounds contain any antibiotics for any illness received; Pregnant and lactating women; people with serious diseases such as congestive heart failure; end-stage renal failure; cirrhosis and psychosis; patients with active gastrointestinal bleeding (upper); previous use of H. pylori eradication regimen and any favism patients were excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradication of Helicobacter pylori. Timepoint: 6 weeks after end of treatment. Method of measurement: UBT.
Secondary Outcome Measures
NameTimeMethod
Side effects of treatment. Timepoint: At the time of treatment. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath